CLASS II Device recall · Reported 8 Oct 2014 · FDA Enforcement Report

Verigene Bc-gn Kit recalled by Nanosphere

Nanosphere is recalling Verigene Bc-gn Kit (, distributed nationwide in the US. The recall was initiated on 17 Jun 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart Number: 20-009-021; Lot Numbers: 052113021C
Quantity recalled20 extraction trays

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2736-2014
FDA event ID
68014
Recalling firm
Nanosphere, Northbrook, IL
Classification
Class II
Status
Terminated
Recall initiated
17 Jun 2013
FDA classified
30 Sep 2014
Reported
8 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

17 Jun 2013Recall initiated by company
30 Sep 2014Classified by FDA+470 days
8 Oct 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.

Product as listed by the FDA

Verigene BC-GN Kit (Catalog number 20-005-021); 1) 20 Verigene BC-GN Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for simultaneous detection and identification of selected gram-positive (BC-GP) and gram-negative (BC-GN) bacteria and resistance markers.

Where it was distributed

Worldwide Distribution:US (Nationwide) including states of: AZ, CA, FL, IL, KY, MD, MN, MT, OH, PA, TN, TX, VA, WA, WI; and countries of: Belgium, China, and Saudi Arabia.

Nationwide ArizonaCaliforniaFloridaIllinoisKentuckyMarylandMinnesotaMontanaOhioPennsylvaniaTennesseeTexasVirginiaWashingtonWisconsin

Questions about this recall

Is Verigene Bc-gn Kit ( recalled?

Yes. Nanosphere recalled Verigene Bc-gn Kit ( on 17 Jun 2013. The recall is Class II and its status is Terminated. Recall number Z-2736-2014.

Why was it recalled?

There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.

Which lots are affected?

Part Number: 20-009-021; Lot Numbers: 052113021C

Where was it sold?

Worldwide Distribution:US (Nationwide) including states of: AZ, CA, FL, IL, KY, MD, MN, MT, OH, PA, TN, TX, VA, WA, WI; and countries of: Belgium, China, and Saudi Arabia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Nanosphere

All 11

Other Test Kits & Diagnostics recalls

All 2,656